Extended Abstract

Elevated Chemokine C-C motif ligand 2 (CCL2) early in pregnancy is associated with increased risk of preeclampsia in obese parturients

Authors: Sarah A. Wernimont (1Department of Obstetrics and Gynecology, Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, 52242) , Sabrina Scroggins (Department of Obstetrics and Gynecology, Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, 52242) , Donna Santillan (Department of Obstetrics and Gynecology, Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, 52242) , Mark K Santillan (Department of Obstetrics and Gynecology, Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, 52242)

Abstract

The objective of this study is to measure plasma CCl2 and leptin early in control and obese women and associate pregnancy outcomes with these levels. We hypothesize that early elevations of plasma CCL2 will be predictive of the development of poor pregnancy outcomes.

Keywords: Pregnancy, preeclampsia, obesity

How to Cite: Wernimont, S. A. , Scroggins, S. , Santillan, D. & Santillan, M. K. (2016) “Elevated Chemokine C-C motif ligand 2 (CCL2) early in pregnancy is associated with increased risk of preeclampsia in obese parturients”, Proceedings in Obstetrics and Gynecology. 6(3). doi: https://doi.org/10.17077/2154-4751.1339